Evaluation of PegIntron in control of hepatitis C Cirrhosis 3
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2010
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms EPIC-3
- Sponsors Schering-Plough
- 18 Apr 2010 Results from EPIC3 were presented at the 45th Annual Meeting of the European Association for the Study of the Liver.
- 30 Oct 2009 Results from EPIC-3 Maintenance Trial presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD).
- 26 Apr 2009 Results from EPIC-3 Maintenance Trial presented at EASL 2009.